GlobeStar Therapeutics Corporation Stock
Stocks
GSTC
US37960P1049
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| Market Cap | 621K 539K 501K 462K 870K 59.24M 885K 5.93M 2.32M 29.42M 2.33M 2.28M 98.95M | P/E 2022 |
-1.56x | P/E 2023 | -0.76x |
|---|---|---|---|---|---|
| Enterprise Value | 987K 857K 796K 734K 1.38M 94.19M 1.41M 9.42M 3.69M 46.78M 3.7M 3.62M 157M | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
93.7% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.05 |
| 10 years | 0 | | 0.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Katzaroff
CEO | Chief Executive Officer | 68 | 2021-03-02 |
David Croom
PRN | Corporate Officer/Principal | - | 2021-05-05 |
Brooke Greenwald
SAM | Sales & Marketing | - | 2021-04-26 |
| Director | Title | Age | Since |
|---|---|---|---|
James Katzaroff
CHM | Chairman | 68 | - |
William Farley
BRD | Director/Board Member | 70 | 2021-04-27 |
| Director/Board Member | - | 2021-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/23/22 | Other | Chief Financial Officer | 3,041,721 | 0.4383% | ||
| 5/12/21 | Others | Chief Executive Officer | 72,042,253 | 15.1464% | ||
| 2/10/21 | Other | CFO | 4,000,000 | 0.8577% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | -96.88% | 1.24K | |
| -0.11% | +4.45% | +0.07% | +13.30% | 49.37B | |
| -1.84% | +14.70% | +24.15% | +5.15% | 39.14B | |
| -0.88% | +1.81% | +419.17% | +647.45% | 40.85B | |
| -2.04% | -1.44% | +7.38% | +43.06% | 35.81B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 30.5B | |
| -0.61% | -0.63% | - | - | 16.55B | |
| -0.55% | -4.54% | +32.10% | +126.95% | 16.14B | |
| -0.46% | -2.81% | -8.80% | -34.35% | 12.77B | |
| +0.03% | +3.37% | +1.96% | +9.68% | 13.71B | |
| Average | -0.07% | +5.46% | +60.96% | +85.10% | 25.49B | |
| Weighted average by Cap. | -0.10% | +7.02% | +80.26% | +134.98% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.49M -1.29M -1.2M -1.11M -2.08M -142M -2.12M -14.21M -5.56M -70.54M -5.59M -5.46M -237M | -1.95M -1.69M -1.57M -1.45M -2.73M -186M -2.78M -18.61M -7.29M -92.42M -7.32M -7.16M -311M |
| Net Debt | 152K 132K 123K 113K 213K 14.54M 217K 1.45M 570K 7.22M 572K 560K 24.29M | 366K 318K 295K 272K 513K 34.94M 522K 3.5M 1.37M 17.35M 1.37M 1.34M 58.36M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- GSTC Stock
Select your edition
All financial news and data tailored to specific country editions
